{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:58:13Z","timestamp":1785491893766,"version":"3.56.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pemphigoid gestationis (PG) is a rare blistering dermatosis usually seen in the second and third trimesters of pregnancy. Treatment of PG is aimed towards the relief of pruritus and prevention of new lesions from developing, often involving high-potency topical corticosteroids, antihistamines, oral corticosteroids and other systemic immune modulators for patients with symptoms of greater severity. Recently, dupilumab, a monoclonal antibody against the alpha subunit of the interleukin-4 receptor, has been used successfully in bullous pemphigoid. We discuss the case of a 34-year-old Asian woman at 32\u2005weeks\u2019 gestation who presented with progressive and severely pruritic oedematous urticarial plaques and patches dispersed across the trunk and extremities, with scattered tense bullae. A skin biopsy confirmed the diagnosis of PG. The patient was placed on high-dose oral corticosteroids and concomitant topical steroids, with minimal resolution after attempts to taper oral steroids over the next 4\u2005weeks. Oral prednisone was continued at 17.5\u2005mg for the remainder of her pregnancy given the risks associated with higher dosages. After delivery, the patient\u2019s disease worsened, requiring an increase in prednisone. Given that the patient was breastfeeding, dupilumab was initiated as a steroid-sparing agent allowing patient to be tapered off prednisone with significant improvement and control of her disease. The safety of dupilumab for infants who are being breastfed remains under discussion. Herein, we discuss the existing literature and considerations regarding pregnancy and breastfeeding for patients with PG on dupilumab.<\/jats:p>","DOI":"10.1093\/skinhd\/vzaf091","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:49:56Z","timestamp":1773233396000},"page":"363-368","source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab for the treatment of pemphigoid gestationis in the setting of breastfeeding: a case report and review of the literature"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8119-5755","authenticated-orcid":false,"given":"Gabriela","family":"Soto-Canetti","sequence":"first","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]},{"name":"Ponce Health Sciences University School of Medicine , Ponce , Puerto Rico,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Navrazhina","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Talia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2026073105082741500_vzaf091-B1"},{"key":"2026073105082741500_vzaf091-B2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","article-title":"Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series","volume":"83","author":"Abdat","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026073105082741500_vzaf091-B3","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/jcm11123367","article-title":"Use of dupilumab in bullous pemphigoid: where are we now?","volume":"11","author":"Russo","year":"2022","journal-title":"J Clin Med"},{"key":"2026073105082741500_vzaf091-B4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/ced.14765","article-title":"Treatment of pemphigoid gestationis with dupilumab","volume":"46","author":"Riquelme-Mc Loughlin","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2026073105082741500_vzaf091-B5","doi-asserted-by":"crossref","first-page":"e1164","DOI":"10.1111\/jdv.19171","article-title":"A case of pemphigoid gestationis successfully treated with dupilumab","volume":"37","author":"Liu","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdcr.2023.08.013","article-title":"Pemphigoid gestationis treated with dupilumab","volume":"41","author":"Chen","year":"2023","journal-title":"JAAD Case Rep"},{"key":"2026073105082741500_vzaf091-B7","first-page":"e752","article-title":"Successful therapy of pemphigoid gestationis with dupilumab \u2013 a new case","volume":"37","author":"Alvarez Martinez","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B8","doi-asserted-by":"crossref","first-page":"604945","DOI":"10.3389\/fmed.2020.604945","article-title":"A systematic review of treatment options and clinical outcomes in pemphigoid gestationis","volume":"7","author":"Genovese","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026073105082741500_vzaf091-B9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamadermatol.2018.2526","article-title":"Dupilumab for the treatment of recalcitrant bullous pemphigoid","volume":"154","author":"Kaye","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2026073105082741500_vzaf091-B10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jdcr.2020.08.001","article-title":"Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report","volume":"6","author":"Mian","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2026073105082741500_vzaf091-B11","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1111\/jdv.16235","article-title":"A case of atopic eczema treated safely with dupilumab during pregnancy and lactation","volume":"34","author":"Kage","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B12","first-page":"5448","article-title":"Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase\u2122)","volume":"25","author":"Khamisy-Farah","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026073105082741500_vzaf091-B13","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.1111\/jdv.19165","article-title":"Dupilumab for atopic dermatitis during pregnancy and breastfeeding: clinical experience in 13 patients","volume":"37","author":"Escol\u00e0","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B14","author":"US Food & Drug Administration","year":"(   2024"},{"key":"2026073105082741500_vzaf091-B15","first-page":"54","article-title":"Biological agents in pregnancy and lactation \u2013 a rational approach","volume":"1","author":"Prabhu","year":"2019","journal-title":"J Skin Sex Transm Dis"},{"key":"2026073105082741500_vzaf091-B16","volume-title":"Drugs and Lactation Database (LactMed)","author":"National Library of Medicine","year":"2024"},{"key":"2026073105082741500_vzaf091-B17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/bfm.2021.0110","article-title":"Monoclonal antibodies during breastfeeding","volume":"16","author":"Anderson","year":"2021","journal-title":"Breastfeed Med"},{"key":"2026073105082741500_vzaf091-B18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jdv.15709","article-title":"European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period","volume":"33","author":"Vestergaard","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000515246","article-title":"Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature","volume":"13","author":"Lobo","year":"2021","journal-title":"Case Rep Dermatol"},{"key":"2026073105082741500_vzaf091-B20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jdv.19512","article-title":"Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: interdisciplinary expert consensus in Northern Europe","volume":"38","author":"Deleuran","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105082741500_vzaf091-B21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/etm.2021.10945","article-title":"Influence of pemphigoid gestationis on pregnancy outcome: a case report and review of the literature","volume":"23","author":"Parfene","year":"2022","journal-title":"Exp Ther Med"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/4\/363\/68628645\/vzaf091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/4\/363\/68628645\/vzaf091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:08:37Z","timestamp":1785488917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/4\/363\/8719106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,26]]},"published-print":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf091","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,6,26]]}}}